Argan, Inc. reported a strong first quarter for fiscal year 2027 with a 50% increase in revenue, reaching a record $290.9 million. This growth was fueled by multiple project completions and a robust $2.8 billion backlog, supported by rising energy demand in North America. The company expects continued topline growth and margin improvement due to strong project execution and a richer project mix. Despite a premium valuation, Argan's solid earnings momentum, expanding margins, and debt-free balance sheet support a positive outlook for long-term investors.
Investor Brad Thomas reviews his worst REIT investments—ARCP, MPW, SAFE, and IIPR—to highlight critical lessons learned. He stresses that broken trust and poor management can destroy value despite attractive yields, as seen with ARCP. The risks of ch...
Evaxion presented new preclinical data for its AI-designed cytomegalovirus (CMV) vaccine candidate EVX-V1 at the International Herpesvirus Workshop 2026. The data show that EVX-V1's multi-component approach, combining novel AI-discovered antigens wit...
Evercore has upgraded Occidental Petroleum (OXY) citing better capital efficiency and successful debt reduction. This upgrade reflects growing optimism driven by expectations of sustained higher commodity prices, supported by positive ratings from bo...
Helus Pharma receives a speculative Buy rating due to its lead drug HLP003, an oral treatment for major depressive disorder showing promising Phase 2 results and FDA Breakthrough Therapy status. The company’s current valuation undervalues HLP003’s po...
A New York legal case, Noah Doe, claims ownership of 39,069 dormant Bitcoin addresses valued at $293 billion under abandoned property laws. This challenges the core principle of Bitcoin self-custody, which relies on private keys, not inactivity, to p...
